Clinical Trial Update: Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1 study evaluating AB011 in CLDN18.2-positive advanced solid tumors including gastric cancer and pancreati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Pancreatic Adenocarcinoma

Drugs mentioned

• AB011

Snippet

Sponsor: CARsgen Therapeutics Co., Ltd. | Conditions: Solid Tumor, Gastric Cancer | Phase 1 | Status: COMPLETED